Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Author(s): Harrington Catherine A, Cauffield Jacintha
Issue: May/Jun 2005 - Veterinary Compounding
View All Articles in Issue
Page(s): 201-205
Download in electronic PDF format for $75
Abstract: Selection of the “best” antihypertensive therapy was an issue of great debate among clinicians in the past. As large meta-analytic studies have shown, all antihypertensive drugs lower blood pressure by about the same amount; the main differences are in their side effects, cost, and frequency of administration. The side effect profiles, along with the patient’s comorbid conditions, should determine the combination of drugs to use. For the most part, side effects from antihypertensive drugs are predictable since they are dose related. When hypertension coexists with other cardiac conditions, drugs that treat both hypertension and other conditions at the same time should be chosen. Physicians should be encouraged to aggressively pursue treatment goals in hypertension, and meta-analysis has shown that combination drug therapy is the best way to reduce doses and side effects while maintaining effectiveness in blood pressure control. Compounded combinations let physicians tailor prescriptions to the patient; individualizing the mix of drugs and doses allows more aggressive treatment while controlling side effects and cost of therapy.
Related Keywords:
hypertension, high blood pressure, antihypertensive medication, combination drug regimens, adverse effects, side effects, drug costs
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A, Cauffield Jacintha
|
May/Jun 2005
Pg. 201-205
|
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Harrington Catherine A, Cauffield Jacintha
|
Mar/Apr 2005
Pg. 117-119
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications
Gilbert John A
|
Sep/Oct 2009
Pg. 400-403
|
Basics of Compounding for Terrorist Attacks, Part 2
Allen Loyd V Jr
|
Mar/Apr 2003
Pg. 129-134
View Sample |
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Williams LaVonn A
|
Mar/Apr 2010
Pg. 105-107
|
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 294-298
|
The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
|
Jul/Aug 2022
Pg. 298-301
|
Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
|
May/Jun 2016
Pg. 202-206
|
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 350-351
|
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
|
Nov/Dec 2012
Pg. 456-460
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jul/Aug 2015
Pg. 295-300
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Mar/Apr 2024
Pg. 111-116
|
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
|
May/Jun 2016
Pg. 217-222
|
Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph, Bennet Daron, Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 95-107
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
|
Nov/Dec 2011
Pg. 526-527
|
Return to Top |